Spots Global Cancer Trial Database for neoplasms, hemoglobin values
Every month we try and update this database with for neoplasms, hemoglobin values cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
PROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation Therapy | NCT00388336 | Anemia Neoplasms | Epoetin Alfa | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
PROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation Therapy | NCT00388336 | Anemia Neoplasms | Epoetin Alfa | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |